Xencor XNCR
NASDAQ XNCR
$39.97 +0.58 (+1.47%)
At close: Nov 11, 2026 · 4:00 PM EST

Xencor (XNCR) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Xencor's Return on Capital Employed [ROCE] came in at -33.29% for Q2 2026, down 15.11 percentage points from -18.18% a year earlier and down 4.33 percentage points from the prior quarter.

Analysis

Xencor (XNCR) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Xencor's Return on Capital Employed [ROCE] was -21.70%, down 1.22 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last four years, with a five-year change of -8.13 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -20.48% in FY2024 (-4.57 pp), -15.91% in FY2023 (-5.32 pp), -10.60% in FY2022 (-16.85 pp) and 6.25% in FY2021 (+19.83 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2014.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of -3.91 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q1 2022 (a gain of 24.91 percentage points), and the weakest in Q1 2023 (a drop of 33.25 percentage points).
  • Business Quant data shows XNCR's Return on Capital Employed [ROCE] at -28.96% (Q1 2026), -22.87% (Q4 2025) and -17.40% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Xencor 2.94 Bn 1.37 Bn - -21.70%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -21.70%
Jun 30, 2026 -33.29%
Mar 31, 2026 -28.96%
Dec 31, 2025 -22.87%
Sep 30, 2025 -17.40%
Jun 30, 2025 -18.18%
Mar 31, 2025 -19.88%
Dec 31, 2024 -20.08%
Sep 30, 2024 -23.22%
Jun 30, 2024 -19.62%
Mar 31, 2024 -14.69%
Dec 31, 2023 -16.59%
Sep 30, 2023 -20.35%
Jun 30, 2023 -22.47%
Mar 31, 2023 -22.33%
Dec 31, 2022 -10.62%
Sep 30, 2022 6.87%
Jun 30, 2022 6.26%
Mar 31, 2022 10.91%
Dec 31, 2021 6.28%
API Access

Xencor Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XNCR&period=max&api_key=YOUR_API_KEY